Yahoo Web Search

Search results

  1. Jan 30, 2023 · What. A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health ...

  2. Apr 22, 2021 · Promising results came early in 2023 when a study in The Lancet showed that an experimental vaccine against Marburg virus (MARV) called cAd3-Marburg was safe and induced an immune response in a small, first-in-human clinical trial.

  3. Jan 30, 2023 · NIAIDNews@niaid.nih.gov. Content last reviewed on January 30, 2023. A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

  4. Dec 19, 2023 · Published Dec 19, 2023. Street Insider. A Marburg virus vaccine tested at Texas Biomedical Research Institute (Texas Biomed) is progressing in clinical trials, moving a step closer towards becoming the world’s first vaccine against the deadly virus.

  5. An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes the disease. There is no licensed treatment for Marburg infection, which has a high fatality rate.

  6. Jan 28, 2023 · Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.

  7. Feb 15, 2023 · 15 February 2023. Correction 17 February 2023. Marburg virus outbreak: researchers race to test vaccines. Control measures such as quarantine could end the outbreak in Equatorial Guinea...

  1. People also search for